id	sid	tid	token	lemma	pos
work_kxfbgxp3ofbvng72zikzrcr6zm	1	1	PIN21	pin21	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	2	THE	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	1	3	CLINICAL	CLINICAL	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	1	4	AND	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	1	5	ECONOMIC	economic	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	6	BURDEN	burden	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	7	OF	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	8	COMPLICATED	complicate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	9	SKIN	skin	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	10	AND	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	1	11	SKIN	SKIN	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	1	12	STRUCTURE	STRUCTURE	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	1	13	INFECTIONS	infection	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	1	14	DUE	due	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	1	15	TO	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	16	STAPHYLOCOCCUS	STAPHYLOCOCCUS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	1	17	AUREUS	AUREUS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	1	18	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	1	19	FINDINGS	findings	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	20	FROM	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	21	A	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	1	22	NATIONAL	NATIONAL	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	1	23	DATABASE	database	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	24	A165Abstracts	a165abstract	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	1	25	Analyses	Analyses	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	1	26	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	1	27	conducted	conduct	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	28	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	29	both	both	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	1	30	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	1	31	societal	societal	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	1	32	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	1	33	health	health	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	34	care	care	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	35	system	system	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	36	perspective	perspective	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	1	37	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	2	1	Sensitivity	sensitivity	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	2	2	analyses	analysis	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	2	3	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	2	4	performed	perform	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	2	5	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	3	1	RESULTS	RESULTS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	3	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	3	3	Reduction	reduction	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	4	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	5	disease	disease	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	6	outcomes	outcome	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	3	7	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	3	8	disease	disease	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	3	9	sequelae	sequelae	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	3	10	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	3	11	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	12	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	3	13	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	14	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	3	15	illness	illness	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	16	by	by	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	17	health	health	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	18	state	state	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	19	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	3	20	observed	observe	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	21	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	22	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	3	23	time	time	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	24	period	period	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	25	post	post	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	3	26	-	-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	3	27	Prevnar	Prevnar	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	3	28	®	®	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	3	29	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	3	30	across	across	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	31	all	all	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	3	32	age	age	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	3	33	groups	group	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	3	34	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	4	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	4	2	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	4	3	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	4	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	5	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	4	6	vac-	vac-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	7	cination	cination	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	8	program	program	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	9	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	10	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	4	11	Canadian	canadian	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	4	12	health	health	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	13	care	care	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	14	system	system	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	15	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	4	16	including	include	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	4	17	herd	herd	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	18	immunity	immunity	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	19	effects	effect	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	4	20	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	4	21	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	4	22	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	23	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	4	24	payer	payer	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	25	perspective	perspective	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	26	amounted	amount	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	4	27	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	28	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	4	29	74,682,790	74,682,790	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	4	30	;	;	:
work_kxfbgxp3ofbvng72zikzrcr6zm	4	31	this	this	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	4	32	decreased	decrease	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	4	33	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	34	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	4	35	46,197,274	46,197,274	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	4	36	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	37	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	4	38	societal	societal	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	4	39	per-	per-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	4	40	spective	spective	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	4	41	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	5	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	5	2	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	5	3	number	number	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	5	4	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	5	5	illnesses	illness	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	5	6	avoided	avoid	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	5	7	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	5	8	86,164	86,164	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	5	9	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	6	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	6	2	incremental	incremental	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	6	3	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	6	4	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	6	5	effectiveness	effectiveness	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	6	6	ratio	ratio	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	6	7	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	6	8	ICER	ICER	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	6	9	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	6	10	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	6	11	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	6	12	28,551	28,551	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	6	13	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	6	14	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	6	15	17,661	17,661	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	6	16	per	per	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	6	17	additional	additional	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	6	18	QALY	qaly	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	6	19	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	6	20	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	6	21	health	health	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	6	22	system	system	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	6	23	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	6	24	soci-	soci-	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	6	25	etal	etal	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	6	26	perspectives	perspective	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	6	27	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	6	28	respectively	respectively	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	6	29	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	7	1	When	when	WRB
work_kxfbgxp3ofbvng72zikzrcr6zm	7	2	herd	herd	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	7	3	immunity	immunity	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	7	4	effects	effect	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	7	5	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	7	6	excluded	exclude	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	7	7	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	7	8	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	7	9	analysis	analysis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	7	10	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	7	11	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	7	12	ICER	ICER	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	7	13	increased	increase	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	7	14	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	7	15	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	7	16	166,560	166,560	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	7	17	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	7	18	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	7	19	115,995	115,995	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	7	20	per	per	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	7	21	QALY	QALY	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	7	22	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	7	23	respectively	respectively	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	7	24	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	8	1	Sensitivity	sensitivity	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	8	2	analysis	analysis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	8	3	indicated	indicate	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	8	4	that	that	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	8	5	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	8	6	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	8	7	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	8	8	ICER	icer	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	8	9	results	result	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	8	10	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	8	11	most	most	RBS
work_kxfbgxp3ofbvng72zikzrcr6zm	8	12	sensitive	sensitive	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	8	13	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	8	14	changes	change	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	8	15	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	8	16	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	8	17	epidemiology	epidemiology	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	8	18	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	8	19	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	8	20	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	8	21	otitis	otitis	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	8	22	media	medium	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	8	23	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	9	1	However	however	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	9	2	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	9	3	these	these	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	9	4	changes	change	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	9	5	did	do	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	9	6	not	not	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	9	7	considerably	considerably	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	9	8	impact	impact	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	9	9	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	9	10	results	result	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	9	11	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	9	12	indicating	indicate	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	9	13	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	9	14	robust	robust	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	9	15	model	model	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	9	16	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	10	1	CONCLUSION	conclusion	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	10	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	10	3	Consistent	consistent	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	10	4	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	10	5	previous	previous	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	10	6	find-	find-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	10	7	ings	ing	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	10	8	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	10	9	vaccination	vaccination	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	10	10	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	10	11	Prevnar	Prevnar	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	10	12	®	®	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	10	13	is	be	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	10	14	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	10	15	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	10	16	effective	effective	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	10	17	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	11	1	Administration	Administration	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	11	2	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	11	3	Prevnar	Prevnar	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	11	4	®	®	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	11	5	results	result	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	11	6	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	11	7	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	11	8	substantial	substantial	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	11	9	reduction	reduction	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	11	10	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	11	11	pneumococcal	pneumococcal	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	11	12	disease	disease	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	11	13	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	11	14	vaccinated	vaccinated	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	11	15	children	child	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	11	16	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	11	17	unvaccinated	unvaccinated	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	11	18	adults	adult	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	11	19	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	12	1	PIN19	pin19	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	2	COST	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	3	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	12	4	EFFECTIVENESS	effectiveness	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	5	OF	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	6	GARGLING	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	7	FOR	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	8	PREVENTION	prevention	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	9	OF	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	10	UPPER	upper	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	12	11	RESPIRATORY	respiratory	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	12	TRACT	TRACT	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	12	13	INFECTIONS	infection	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	12	14	Shimbo	Shimbo	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	15	T1	T1	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	16	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	17	Omata	Omata	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	18	K1	K1	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	19	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	20	Takahashi	Takahashi	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	21	Y1	Y1	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	22	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	23	Satomura	Satomura	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	24	K2	K2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	25	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	26	Kitamura	Kitamura	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	27	T3	T3	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	28	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	29	Kawamura	Kawamura	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	30	T2	T2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	31	1International	1International	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	32	Medical	Medical	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	33	Center	Center	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	34	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	35	Japan	Japan	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	36	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	37	Shinjyuku	Shinjyuku	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	38	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	12	39	ku	ku	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	40	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	41	Tokyo	Tokyo	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	42	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	43	Japan	Japan	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	44	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	45	2Kyoto	2Kyoto	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	46	University	University	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	47	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	48	Kyoto	Kyoto	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	49	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	50	Kyoto	Kyoto	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	51	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	52	Japan	Japan	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	53	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	54	3Osaka	3Osaka	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	55	Saiseikai	Saiseikai	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	56	Senri	Senri	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	57	Hospital	Hospital	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	58	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	59	Suita	Suita	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	60	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	61	Osaka	Osaka	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	62	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	12	63	Japan	Japan	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	64	OBJECTIVES	OBJECTIVES	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	65	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	12	66	To	to	TO
work_kxfbgxp3ofbvng72zikzrcr6zm	12	67	investigate	investigate	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	12	68	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	12	69	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	70	effectiveness	effectiveness	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	71	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	72	gargling	gargle	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	12	73	to	to	TO
work_kxfbgxp3ofbvng72zikzrcr6zm	12	74	prevent	prevent	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	12	75	upper	upper	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	12	76	respiratory	respiratory	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	12	77	tract	tract	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	78	infections	infection	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	12	79	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	12	80	URI	URI	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	12	81	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	12	82	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	83	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	12	84	societal	societal	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	12	85	perspective	perspective	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	12	86	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	13	1	METHODS	METHODS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	13	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	13	3	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	13	4	effectiveness	effectiveness	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	5	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	6	gargling	gargle	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	13	7	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	8	pre-	pre-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	9	venting	vent	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	13	10	URI	uri	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	11	has	have	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	13	12	been	be	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	13	demonstrated	demonstrate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	14	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	15	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	13	16	randomized	randomized	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	13	17	controlled	controlled	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	13	18	trial	trial	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	19	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	20	which	which	WDT
work_kxfbgxp3ofbvng72zikzrcr6zm	13	21	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	13	22	participants	participant	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	13	23	recorded	record	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	13	24	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	13	25	frequency	frequency	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	26	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	27	gargling	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	28	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	13	29	incidence	incidence	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	30	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	13	31	severity	severity	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	32	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	33	URI	uri	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	34	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	13	35	duration	duration	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	36	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	37	daily	daily	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	13	38	medicine	medicine	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	13	39	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	14	1	Costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	14	2	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	14	3	gargling	gargle	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	14	4	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	14	5	visiting	visit	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	14	6	physicians	physician	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	14	7	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	14	8	medicine	medicine	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	14	9	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	14	10	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	14	11	lost	lose	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	14	12	pro-	pro-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	14	13	ductivity	ductivity	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	14	14	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	14	15	considered	consider	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	14	16	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	15	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	15	2	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	3	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	4	gargling	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	5	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	15	6	estimated	estimate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	7	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	8	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	15	9	opportunity	opportunity	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	10	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	11	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	12	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	15	13	time	time	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	14	required	require	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	15	15	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	16	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	16	2	utility	utility	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	16	3	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	16	4	severe	severe	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	16	5	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	16	6	moderate	moderate	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	16	7	URI	URI	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	16	8	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	16	9	also	also	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	16	10	considered	consider	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	16	11	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	17	1	Average	average	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	17	2	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	17	3	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	17	4	utility	utility	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	5	during	during	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	6	60	60	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	17	7	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	17	8	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	9	observation	observation	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	10	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	11	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	17	12	trial	trial	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	13	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	17	14	estimated	estimate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	15	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	16	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	17	17	sum	sum	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	18	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	19	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	17	20	average	average	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	17	21	daily	daily	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	17	22	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	23	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	17	24	utility	utility	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	25	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	26	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	17	27	participants	participant	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	17	28	remaining	remain	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	17	29	staying	stay	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	17	30	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	31	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	17	32	trial	trial	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	17	33	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	18	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	18	2	incremental	incremental	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	18	3	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	4	effectiveness	effectiveness	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	5	ratio	ratio	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	6	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	18	7	ICER	ICER	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	18	8	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	18	9	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	10	gargling	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	11	when	when	WRB
work_kxfbgxp3ofbvng72zikzrcr6zm	18	12	compared	compare	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	13	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	14	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	18	15	absence	absence	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	16	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	17	gar-	gar-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	18	18	gling	gling	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	18	19	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	18	20	calculated	calculate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	21	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	18	22	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	18	23	bootstrap	bootstrap	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	24	sampling	sampling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	25	generated	generate	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	18	26	an	an	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	18	27	acceptability	acceptability	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	28	curve	curve	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	18	29	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	19	1	RESULTS	RESULTS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	19	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	19	3	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	19	4	estimated	estimate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	19	5	unit	unit	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	19	6	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	19	7	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	19	8	gar-	gar-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	19	9	gling	gling	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	19	10	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	19	11	49.2	49.2	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	19	12	yen	yen	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	19	13	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	20	1	Assigned	assign	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	20	2	participants	participant	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	20	3	gargled	gargle	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	20	4	4.5	4.5	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	20	5	times	time	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	20	6	per	per	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	20	7	day	day	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	20	8	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	20	9	average	average	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	20	10	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	21	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	21	2	gargling	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	21	3	group	group	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	21	4	had	have	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	21	5	higher	high	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	21	6	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	21	7	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	21	8	utility	utility	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	21	9	than	than	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	21	10	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	21	11	group	group	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	21	12	that	that	WDT
work_kxfbgxp3ofbvng72zikzrcr6zm	21	13	did	do	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	21	14	not	not	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	21	15	gargle	gargle	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	21	16	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	22	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	22	2	incremental	incremental	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	22	3	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	22	4	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	22	5	effectiveness	effectiveness	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	22	6	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	22	7	60	60	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	22	8	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	22	9	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	22	10	4750	4750	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	22	11	yen	yen	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	22	12	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	22	13	0.43	0.43	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	22	14	quality-	quality-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	22	15	adjusted	adjusted	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	22	16	life	life	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	22	17	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	22	18	respectively	respectively	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	22	19	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	23	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	23	2	gargling	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	23	3	group	group	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	23	4	required	require	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	23	5	8020	8020	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	23	6	yen	yen	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	23	7	more	more	RBR
work_kxfbgxp3ofbvng72zikzrcr6zm	23	8	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	23	9	gargling	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	23	10	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	23	11	but	but	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	23	12	saved	save	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	23	13	3270	3270	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	23	14	yen	yen	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	23	15	by	by	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	23	16	preventing	prevent	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	23	17	URI	uri	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	23	18	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	23	19	60	60	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	23	20	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	23	21	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	24	1	This	this	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	24	2	showed	show	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	24	3	that	that	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	24	4	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	24	5	ICER	icer	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	24	6	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	24	7	gargling	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	24	8	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	24	9	4.07	4.07	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	24	10	million	million	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	24	11	yen	yen	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	24	12	/	/	SYM
work_kxfbgxp3ofbvng72zikzrcr6zm	24	13	QALYs	QALYs	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	24	14	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	24	15	34,400	34,400	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	24	16	US$	us$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	24	17	/QALYs	/QALYs	.
work_kxfbgxp3ofbvng72zikzrcr6zm	24	18	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	24	19	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	25	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	25	2	acceptability	acceptability	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	25	3	curve	curve	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	25	4	showed	show	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	25	5	67.1	67.1	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	25	6	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	25	7	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	25	8	less	less	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	25	9	than	than	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	25	10	6	6	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	25	11	million	million	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	25	12	yen	yen	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	25	13	/	/	SYM
work_kxfbgxp3ofbvng72zikzrcr6zm	25	14	QALYs	QALYs	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	25	15	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	25	16	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	25	17	88.7	88.7	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	25	18	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	25	19	less	less	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	25	20	than	than	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	25	21	12	12	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	25	22	million	million	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	25	23	yen	yen	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	25	24	/	/	SYM
work_kxfbgxp3ofbvng72zikzrcr6zm	25	25	QALYs	QALYs	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	25	26	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	26	1	CONCLUSION	conclusion	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	26	3	Although	although	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	4	it	-PRON-	PRP
work_kxfbgxp3ofbvng72zikzrcr6zm	26	5	can	can	MD
work_kxfbgxp3ofbvng72zikzrcr6zm	26	6	prevent	prevent	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	26	7	URI	uri	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	8	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	26	9	gargling	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	10	is	be	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	26	11	more	more	RBR
work_kxfbgxp3ofbvng72zikzrcr6zm	26	12	costly	costly	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	26	13	than	than	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	14	not	not	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	26	15	gargling	gargle	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	26	16	because	because	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	17	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	26	18	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	19	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	20	gargling	gargle	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	26	21	exceeded	exceed	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	26	22	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	26	23	savings	saving	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	26	24	derived	derive	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	25	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	26	URI	URI	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	26	27	prevention	prevention	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	26	28	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	27	1	However	however	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	27	2	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	27	3	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	27	4	ICER	icer	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	27	5	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	27	6	gargling	gargling	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	27	7	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	27	8	comparable	comparable	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	27	9	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	27	10	that	that	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	27	11	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	27	12	other	other	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	27	13	widespread	widespread	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	27	14	medical	medical	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	27	15	technologies	technology	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	27	16	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	28	1	PIN20	PIN20	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	2	PHARMACOECONOMIC	pharmacoeconomic	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	28	3	ANALYSIS	analysi	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	28	4	OF	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	5	SEVERE	SEVERE	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	6	COMMUNITY-	COMMUNITY-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	7	ACQUIRED	ACQUIRED	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	8	PNEUMONIA	pneumonia	VBP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	9	TREATMENT	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	10	Kulikov	Kulikov	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	11	A	a	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	12	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	28	13	Krysanov	Krysanov	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	14	I	I	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	15	Moscow	Moscow	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	16	Medical	Medical	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	17	Academy	Academy	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	18	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	28	19	Moscow	Moscow	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	20	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	28	21	Russia	Russia	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	22	OBJECTIVES	OBJECTIVES	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	28	23	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	28	24	Selection	selection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	25	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	26	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	28	27	most	most	RBS
work_kxfbgxp3ofbvng72zikzrcr6zm	28	28	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	29	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	28	30	effective	effective	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	28	31	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	32	regimen	regiman	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	28	33	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	34	severe	severe	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	28	35	community	community	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	36	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	28	37	acquired	acquire	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	38	pneumonia	pneumonia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	28	39	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	29	1	METHODS	methods	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	29	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	29	3	Direct	direct	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	29	4	medical	medical	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	29	5	expenditure	expenditure	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	29	6	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	29	7	courses	course	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	29	8	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	29	9	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	29	10	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	29	11	lev-	lev-	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	29	12	ofloxacin	ofloxacin	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	29	13	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	29	14	ceftriaxone	ceftriaxone	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	29	15	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	29	16	evaluated	evaluate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	29	17	during	during	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	29	18	this	this	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	29	19	trial	trial	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	29	20	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	30	1	“	"	``
work_kxfbgxp3ofbvng72zikzrcr6zm	30	2	Cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	30	3	minimization	minimization	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	30	4	”	"	''
work_kxfbgxp3ofbvng72zikzrcr6zm	30	5	analysis	analysis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	30	6	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	30	7	chosen	choose	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	30	8	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	30	9	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	30	10	pharmacoeconomic	pharmacoeconomic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	30	11	method	method	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	30	12	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	30	13	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	30	14	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	30	15	“	"	``
work_kxfbgxp3ofbvng72zikzrcr6zm	30	16	lost	lost	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	30	17	opportunities	opportunity	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	30	18	”	"	''
work_kxfbgxp3ofbvng72zikzrcr6zm	30	19	index	index	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	30	20	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	30	21	calculated	calculate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	30	22	when	when	WRB
work_kxfbgxp3ofbvng72zikzrcr6zm	30	23	using	use	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	30	24	less	less	RBR
work_kxfbgxp3ofbvng72zikzrcr6zm	30	25	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	30	26	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	30	27	effective	effective	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	30	28	drugs	drug	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	30	29	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	31	1	RESULTS	RESULTS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	31	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	31	3	Direct	direct	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	31	4	medical	medical	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	31	5	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	31	6	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	7	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	31	8	group	group	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	9	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	10	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	31	11	who	who	WP
work_kxfbgxp3ofbvng72zikzrcr6zm	31	12	received	receive	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	31	13	levofloxacin	levofloxacin	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	31	14	amounted	amount	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	31	15	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	16	16,097.99	16,097.99	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	31	17	rubles	ruble	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	31	18	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	31	19	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	31	20	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	21	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	31	22	group	group	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	23	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	24	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	31	25	who	who	WP
work_kxfbgxp3ofbvng72zikzrcr6zm	31	26	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	31	27	treated	treat	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	28	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	29	ceftriaxone	ceftriaxone	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	30	they	-PRON-	PRP
work_kxfbgxp3ofbvng72zikzrcr6zm	31	31	totaled	total	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	31	32	32,573.47	32,573.47	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	31	33	rubles	ruble	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	31	34	per	per	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	35	patient	patient	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	31	36	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	32	1	They	-PRON-	PRP
work_kxfbgxp3ofbvng72zikzrcr6zm	32	2	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	32	3	made	make	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	32	4	up	up	RP
work_kxfbgxp3ofbvng72zikzrcr6zm	32	5	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	32	6	levofloxacin	levofloxacin	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	32	7	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	32	8	ceftriaxone	ceftriaxone	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	32	9	antibacterial	antibacterial	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	32	10	drug	drug	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	32	11	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	32	12	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	32	13	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	32	14	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	32	15	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	32	16	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	32	17	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	32	18	’	’	POS
work_kxfbgxp3ofbvng72zikzrcr6zm	32	19	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	32	20	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	32	21	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	33	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	33	2	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	3	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	4	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	33	5	drug	drug	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	6	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	7	course	course	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	8	amounted	amount	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	33	9	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	10	3,997.99	3,997.99	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	33	11	rubles	ruble	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	33	12	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	13	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	33	14	first	first	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	33	15	group	group	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	16	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	33	17	levofloxacin	levofloxacin	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	33	18	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	33	19	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	33	20	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	21	19,073.47	19,073.47	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	33	22	rubles	ruble	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	33	23	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	24	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	33	25	second	second	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	33	26	group	group	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	27	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	33	28	ceftriaxone	ceftriaxone	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	29	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	33	30	;	;	:
work_kxfbgxp3ofbvng72zikzrcr6zm	33	31	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	33	32	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	33	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	34	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	35	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	36	amounted	amount	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	33	37	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	33	38	12,100	12,100	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	33	39	rubles	ruble	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	33	40	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	33	41	13,500	13,500	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	33	42	rubles	ruble	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	33	43	respectively	respectively	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	33	44	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	34	1	In	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	2	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	34	3	break-	break-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	4	down	down	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	5	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	6	expenditure	expenditure	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	7	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	8	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	9	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	10	community	community	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	11	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	34	12	acquired	acquire	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	13	pneu-	pneu-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	14	monia	monia	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	34	15	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	16	levofloxacin	levofloxacin	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	34	17	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	34	18	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	34	19	’	’	POS
work_kxfbgxp3ofbvng72zikzrcr6zm	34	20	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	21	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	22	accounted	account	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	34	23	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	24	75	75	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	34	25	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	26	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	27	expenses	expense	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	34	28	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	34	29	whereas	whereas	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	30	drug	drug	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	31	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	32	accounted	account	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	34	33	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	34	only	only	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	34	35	25	25	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	34	36	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	37	thereof	thereof	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	34	38	;	;	:
work_kxfbgxp3ofbvng72zikzrcr6zm	34	39	when	when	WRB
work_kxfbgxp3ofbvng72zikzrcr6zm	34	40	treating	treat	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	34	41	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	42	ceftriaxone	ceftriaxone	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	43	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	34	44	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	34	45	expenditure	expenditure	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	46	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	47	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	34	48	’	’	POS
work_kxfbgxp3ofbvng72zikzrcr6zm	34	49	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	50	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	51	amounted	amount	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	34	52	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	53	40	40	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	34	54	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	55	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	34	56	that	that	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	34	57	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	58	drug	drug	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	59	treat-	treat-	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	34	60	ment	ment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	61	—	—	:
work_kxfbgxp3ofbvng72zikzrcr6zm	34	62	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	63	60	60	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	34	64	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	34	65	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	35	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	2	“	"	``
work_kxfbgxp3ofbvng72zikzrcr6zm	35	3	lost	lost	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	4	opportunities	opportunity	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	35	5	”	"	''
work_kxfbgxp3ofbvng72zikzrcr6zm	35	6	index	index	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	7	equaled	equal	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	35	8	one	one	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	35	9	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	35	10	thus	thus	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	35	11	indicated	indicate	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	35	12	that	that	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	13	when	when	WRB
work_kxfbgxp3ofbvng72zikzrcr6zm	35	14	using	use	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	35	15	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	16	more	more	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	35	17	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	18	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	35	19	effective	effective	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	20	drug	drug	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	21	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	35	22	lev-	lev-	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	35	23	ofloxacin	ofloxacin	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	35	24	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	35	25	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	26	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	27	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	28	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	29	one	one	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	35	30	patient	patient	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	31	compared	compare	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	32	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	33	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	34	less	less	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	35	35	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	36	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	35	37	effective	effective	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	38	drug	drug	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	39	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	35	40	ceftriaxone	ceftriaxone	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	41	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	35	42	it	-PRON-	PRP
work_kxfbgxp3ofbvng72zikzrcr6zm	35	43	is	be	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	44	possible	possible	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	45	to	to	TO
work_kxfbgxp3ofbvng72zikzrcr6zm	35	46	theoretically	theoretically	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	35	47	treat	treat	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	35	48	an	an	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	49	additional	additional	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	50	patient	patient	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	51	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	35	52	taking	take	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	35	53	into	into	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	54	account	account	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	55	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	56	difference	difference	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	57	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	58	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	59	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	35	60	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	61	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	62	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	63	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	64	drugs	drug	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	35	65	compared	compare	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	66	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	35	67	provided	provide	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	35	68	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	69	profile	profile	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	70	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	71	antibiotic	antibiotic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	72	resistance	resistance	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	73	is	be	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	74	congruent	congruent	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	75	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	76	that	that	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	77	under	under	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	78	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	79	conditions	condition	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	35	80	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	81	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	35	82	clinical	clinical	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	35	83	study	study	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	35	84	used	use	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	35	85	herein	herein	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	35	86	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	36	1	CONCLUSION	conclusion	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	36	3	Antibacterial	antibacterial	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	36	4	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	5	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	6	severe	severe	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	36	7	community	community	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	8	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	36	9	acquired	acquire	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	10	pneumo-	pneumo-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	36	11	nia	nia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	12	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	13	levofloxacin	levofloxacin	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	36	14	is	be	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	36	15	more	more	RBR
work_kxfbgxp3ofbvng72zikzrcr6zm	36	16	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	17	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	36	18	effective	effective	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	36	19	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	36	20	enabling	enable	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	36	21	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	36	22	reduc-	reduc-	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	36	23	tion	tion	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	24	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	25	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	36	26	by	by	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	27	16,475	16,475	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	36	28	rubles	ruble	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	36	29	per	per	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	30	patient	patient	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	31	compared	compare	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	32	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	33	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	34	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	35	ceftriaxone	ceftriaxone	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	36	owing	owing	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	37	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	38	lower	low	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	36	39	expenditure	expenditure	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	40	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	36	41	drugs	drug	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	36	42	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	37	1	PIN21	pin21	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	2	THE	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	37	3	CLINICAL	CLINICAL	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	4	AND	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	37	5	ECONOMIC	economic	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	6	BURDEN	burden	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	7	OF	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	8	COMPLICATED	complicate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	9	SKIN	skin	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	10	AND	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	37	11	SKIN	SKIN	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	12	STRUCTURE	STRUCTURE	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	13	INFECTIONS	infection	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	37	14	DUE	due	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	37	15	TO	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	16	STAPHYLOCOCCUS	STAPHYLOCOCCUS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	17	AUREUS	AUREUS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	18	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	37	19	FINDINGS	findings	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	20	FROM	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	21	A	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	37	22	NATIONAL	NATIONAL	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	23	DATABASE	database	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	24	Marton	Marton	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	25	JP1	JP1	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	26	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	27	Menzin	Menzin	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	28	J2	J2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	29	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	30	Sussman	Sussman	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	31	M2	M2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	32	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	33	Friedman	Friedman	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	34	M2	M2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	35	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	36	Philburn	Philburn	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	37	RT1	RT1	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	38	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	39	Rothermel	Rothermel	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	40	CD1	CD1	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	41	1Pfizer	1Pfizer	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	42	Global	Global	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	43	Pharmaceuticals	Pharmaceuticals	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	37	44	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	45	Pfizer	Pfizer	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	46	Inc	Inc	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	47	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	48	New	New	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	49	York	York	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	50	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	51	NY	NY	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	52	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	53	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	54	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	55	2Boston	2Boston	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	56	Health	Health	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	57	Economics	Economics	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	58	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	59	Inc	Inc	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	60	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	61	Waltham	Waltham	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	62	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	63	MA	MA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	64	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	37	65	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	66	OBJECTIVES	OBJECTIVES	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	67	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	37	68	Complicated	complicate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	69	skin	skin	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	70	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	37	71	skin	skin	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	72	structure	structure	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	73	infections	infection	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	37	74	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	37	75	cSSSIs	csssis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	76	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	37	77	are	be	VBP
work_kxfbgxp3ofbvng72zikzrcr6zm	37	78	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	37	79	common	common	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	37	80	complication	complication	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	81	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	37	82	hospitalized	hospitalized	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	37	83	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	37	84	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	38	1	There	there	EX
work_kxfbgxp3ofbvng72zikzrcr6zm	38	2	are	be	VBP
work_kxfbgxp3ofbvng72zikzrcr6zm	38	3	limited	limited	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	38	4	national	national	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	38	5	data	datum	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	38	6	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	38	7	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	38	8	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	38	9	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	38	10	cSSSIs	csssis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	38	11	due	due	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	38	12	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	38	13	Staphylococcus	Staphylococcus	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	38	14	aureus	aureus	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	38	15	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	38	16	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	38	17	common	common	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	38	18	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	38	19	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	38	20	acquired	acquire	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	38	21	pathogen	pathogen	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	38	22	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	39	1	METHODS	methods	LS
work_kxfbgxp3ofbvng72zikzrcr6zm	39	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	39	3	This	this	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	39	4	retrospective	retrospective	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	39	5	cohort	cohort	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	39	6	study	study	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	39	7	used	use	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	39	8	data	datum	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	39	9	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	39	10	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	39	11	2004	2004	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	39	12	Health	Health	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	39	13	care	care	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	39	14	Cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	39	15	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	39	16	Utilization	Utilization	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	39	17	Project	Project	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	39	18	Nationwide	Nationwide	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	39	19	Inpa-	Inpa-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	39	20	tient	tient	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	39	21	Sample	sample	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	39	22	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	39	23	HCUP	HCUP	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	39	24	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	39	25	NIS	NIS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	39	26	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	39	27	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	40	1	Patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	40	2	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	3	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	40	4	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	5	cSSSIs	cSSSIs	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	40	6	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	40	7	identified	identify	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	8	based	base	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	9	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	10	ICD-9-CM	ICD-9-CM	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	40	11	diagnosis	diagnosis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	12	codes	code	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	40	13	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	40	14	compared	compare	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	15	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	16	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	40	17	without	without	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	18	skin	skin	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	40	19	infections	infection	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	40	20	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	41	1	Excess	excess	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	41	2	mortality	mortality	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	41	3	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	41	4	length	length	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	41	5	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	41	6	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	41	7	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	41	8	LOS	LOS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	41	9	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	41	10	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	41	11	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	41	12	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	41	13	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	41	14	estimated	estimate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	41	15	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	41	16	both	both	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	41	17	groups	group	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	41	18	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	42	1	Multivariate	multivariate	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	42	2	models	model	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	42	3	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	42	4	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	5	log	log	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	6	transformation	transformation	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	7	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	42	8	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	42	9	used	use	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	10	to	to	TO
work_kxfbgxp3ofbvng72zikzrcr6zm	42	11	adjust	adjust	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	42	12	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	42	13	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	14	potential	potential	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	42	15	confounding	confounding	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	16	factors	factor	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	42	17	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	42	18	including	include	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	42	19	age	age	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	20	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	42	21	gender	gender	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	22	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	42	23	mortality	mortality	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	24	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	42	25	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	26	region	region	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	27	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	42	28	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	42	29	comorbidity	comorbidity	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	42	30	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	43	1	RESULTS	RESULTS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	43	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	43	3	We	-PRON-	PRP
work_kxfbgxp3ofbvng72zikzrcr6zm	43	4	identified	identify	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	43	5	55,585	55,585	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	43	6	hospitalized	hospitalized	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	43	7	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	43	8	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	43	9	cSSSIs	cSSSIs	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	43	10	due	due	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	43	11	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	43	12	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	43	13	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	43	14	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	44	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	44	2	compari-	compari-	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	44	3	son	son	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	44	4	cohort	cohort	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	44	5	consisted	consist	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	44	6	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	44	7	7,618,776	7,618,776	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	44	8	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	44	9	without	without	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	44	10	skin	skin	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	44	11	infec-	infec-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	44	12	tions	tion	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	44	13	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	45	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	45	2	mortality	mortality	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	45	3	rates	rate	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	45	4	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	45	5	similar	similar	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	45	6	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	45	7	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	45	8	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	45	9	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	45	10	cSSSI	csssi	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	45	11	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	45	12	comparison	comparison	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	45	13	cohorts	cohort	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	45	14	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	45	15	3.9	3.9	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	45	16	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	45	17	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	45	18	2.0	2.0	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	45	19	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	45	20	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	45	21	respectively	respectively	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	45	22	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	45	23	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	46	1	For	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	46	2	com-	com-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	46	3	A166	A166	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	46	4	Abstracts	Abstracts	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	46	5	parison	parison	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	46	6	purposes	purpose	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	46	7	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	46	8	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	46	9	mortality	mortality	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	46	10	rate	rate	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	46	11	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	46	12	all	all	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	46	13	inpatients	inpatient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	46	14	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	46	15	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	46	16	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	46	17	infections	infection	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	46	18	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	46	19	7.3	7.3	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	46	20	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	46	21	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	47	1	Patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	47	2	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	3	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	47	4	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	5	cSSSIs	csssis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	6	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	47	7	older	old	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	47	8	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	47	9	mean	mean	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	47	10	age	age	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	11	54	54	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	47	12	years	year	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	47	13	vs.	vs.	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	47	14	46	46	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	47	15	years	year	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	47	16	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	17	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	47	18	comparison	comparison	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	19	group	group	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	20	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	47	21	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	47	22	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	47	23	more	more	RBR
work_kxfbgxp3ofbvng72zikzrcr6zm	47	24	likely	likely	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	47	25	to	to	TO
work_kxfbgxp3ofbvng72zikzrcr6zm	47	26	have	have	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	47	27	congestive	congestive	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	47	28	heart	heart	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	29	failure	failure	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	30	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	47	31	diabetes	diabete	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	47	32	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	33	chronic	chronic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	47	34	complications	complication	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	47	35	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	47	36	bacteremia	bacteremia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	37	/	/	SYM
work_kxfbgxp3ofbvng72zikzrcr6zm	47	38	septicemia	septicemia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	47	39	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	48	1	Relative	relative	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	48	2	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	3	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	48	4	comparison	comparison	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	5	group	group	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	6	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	48	7	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	48	8	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	9	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	48	10	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	11	cSSSIs	csssis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	12	had	have	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	48	13	significantly	significantly	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	48	14	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	48	15	P	p	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	16	<	<	XX
work_kxfbgxp3ofbvng72zikzrcr6zm	48	17	0.0001	0.0001	LS
work_kxfbgxp3ofbvng72zikzrcr6zm	48	18	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	48	19	longer	longer	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	48	20	mean	mean	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	48	21	length	length	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	22	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	23	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	24	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	48	25	9.7	9.7	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	48	26	vs.	vs.	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	27	4.4	4.4	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	48	28	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	48	29	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	48	30	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	48	31	higher	high	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	48	32	average	average	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	48	33	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	48	34	per	per	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	35	stay	stay	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	48	36	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	48	37	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	48	38	16,941	16,941	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	48	39	vs.	vs.	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	48	40	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	48	41	9,154	9,154	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	48	42	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	48	43	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	49	1	After	after	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	49	2	con-	con-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	49	3	trolling	troll	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	49	4	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	49	5	potentially	potentially	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	49	6	confounding	confound	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	49	7	factors	factor	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	49	8	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	49	9	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	49	10	excess	excess	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	49	11	mean	mean	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	49	12	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	49	13	associated	associate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	49	14	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	49	15	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	49	16	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	49	17	cSSSIs	csssis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	49	18	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	49	19	estimated	estimate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	49	20	to	to	TO
work_kxfbgxp3ofbvng72zikzrcr6zm	49	21	be	be	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	49	22	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	49	23	3,396	3,396	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	49	24	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	50	1	CONCLUSION	conclusion	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	50	3	Our	-PRON-	PRP$
work_kxfbgxp3ofbvng72zikzrcr6zm	50	4	findings	finding	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	50	5	suggest	suggest	VBP
work_kxfbgxp3ofbvng72zikzrcr6zm	50	6	that	that	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	7	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	50	8	clinical	clinical	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	50	9	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	50	10	eco-	eco-	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	50	11	nomic	nomic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	50	12	burden	burden	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	13	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	14	complicated	complicated	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	50	15	skin	skin	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	16	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	50	17	skin	skin	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	18	structure	structure	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	19	infections	infection	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	50	20	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	50	21	cSSSIs	csssis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	22	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	50	23	due	due	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	24	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	25	Staphylococcus	Staphylococcus	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	50	26	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	27	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	50	28	hospitalized	hospitalized	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	50	29	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	50	30	is	be	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	50	31	substantial	substantial	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	50	32	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	51	1	PIN22	PIN22	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	51	2	IMPACT	IMPACT	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	51	3	OF	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	51	4	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	51	5	AUREUS	AUREUS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	51	6	INFECTIONS	infection	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	51	7	ON	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	51	8	EXPENDITURES	EXPENDITURES	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	51	9	AND	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	51	10	LENGTH	LENGTH	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	51	11	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	51	12	OF	OF	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	51	13	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	51	14	STAY	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	51	15	IN	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	51	16	U.S.	U.S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	1	HOSPITALS	HOSPITALS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	2	Noskin	Noskin	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	3	G1	G1	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	4	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	5	Rubin	Rubin	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	6	R2	R2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	7	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	8	Schentag	Schentag	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	9	J3	J3	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	10	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	11	Kluytmans	Kluytmans	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	12	J4	J4	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	13	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	14	Hedblom	Hedblom	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	15	E5	e5	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	16	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	17	Jacobson	Jacobson	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	18	C5	C5	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	19	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	20	Smulders	Smulders	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	21	M6	M6	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	22	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	23	Gemmen	Gemmen	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	24	EK7	EK7	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	25	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	26	Bharmal	Bharmal	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	27	M7	M7	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	28	1Northwestern	1Northwestern	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	29	University	University	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	30	Feinberg	Feinberg	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	31	School	School	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	32	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	33	Medicine	Medicine	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	34	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	35	Chicago	Chicago	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	36	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	37	IL	IL	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	38	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	39	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	40	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	41	2Georgetown	2Georgetown	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	42	University	University	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	43	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	44	Washington	Washington	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	45	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	46	DC	DC	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	47	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	48	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	49	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	50	3University	3University	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	51	at	at	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	52	Buffalo	Buffalo	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	53	School	School	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	54	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	55	Pharmacy	Pharmacy	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	56	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	57	Buffalo	Buffalo	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	58	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	59	NY	NY	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	60	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	61	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	62	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	63	4Amphia	4Amphia	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	64	Hospital	Hospital	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	65	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	52	66	VUmc	VUmc	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	67	Medical	Medical	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	68	University	University	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	69	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	70	Amsterdam	Amsterdam	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	71	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	72	4800	4800	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	52	73	RK	RK	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	74	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	75	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	52	76	Netherlands	Netherlands	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	77	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	78	53	53	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	52	79	M	M	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	80	Medical	Medical	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	81	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	82	St	St	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	83	Paul	Paul	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	84	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	85	MN	MN	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	86	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	87	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	88	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	89	6Quintiles	6Quintiles	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	90	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	91	Falls	Falls	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	92	Church	Church	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	93	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	94	VA	VA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	95	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	96	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	97	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	98	7Quintiles	7Quintiles	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	99	Strategic	Strategic	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	100	Research	Research	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	101	&	&	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	52	102	Safety	Safety	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	103	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	104	Falls	Falls	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	105	Church	Church	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	106	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	107	VA	VA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	108	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	52	109	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	110	OBJECTIVES	OBJECTIVES	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	111	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	52	112	Evaluate	evaluate	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	52	113	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	52	114	incremental	incremental	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	52	115	impact	impact	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	116	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	117	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	118	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	119	infection	infection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	120	stays	stay	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	52	121	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	122	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	123	charges	charge	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	52	124	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	52	125	length	length	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	126	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	52	127	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	128	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	52	129	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	130	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	131	U.S.	U.S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	52	132	hospitals	hospital	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	52	133	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	52	134	2003	2003	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	52	135	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	53	1	METHODS	METHODS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	53	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	53	3	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	53	4	2003	2003	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	53	5	Nationwide	Nationwide	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	53	6	Inpatient	Inpatient	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	53	7	Sample	Sample	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	53	8	data	datum	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	53	9	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	53	10	analyzed	analyze	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	53	11	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	54	1	Hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	2	discharges	discharge	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	54	3	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	54	4	classified	classify	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	5	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	6	either	either	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	54	7	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	54	8	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	54	9	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	10	–	–	:
work_kxfbgxp3ofbvng72zikzrcr6zm	54	11	related	related	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	54	12	infection	infection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	13	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	14	or	or	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	54	15	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	54	16	non	non	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	54	17	-	-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	18	S.	s.	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	54	19	aureus-	aureus-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	20	related	related	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	54	21	infection	infection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	22	stay	stay	VBP
work_kxfbgxp3ofbvng72zikzrcr6zm	54	23	using	use	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	54	24	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	54	25	combination	combination	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	26	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	54	27	several	several	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	54	28	ICD-9	ICD-9	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	54	29	codes	code	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	54	30	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	55	1	Incremental	incremental	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	55	2	effect	effect	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	3	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	4	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	55	5	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	6	infection	infection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	7	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	8	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	9	charges	charge	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	55	10	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	55	11	length	length	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	12	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	55	13	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	14	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	55	15	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	16	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	55	17	estimated	estimate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	18	using	use	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	55	19	multivariate	multivariate	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	20	regression	regression	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	21	models	model	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	55	22	adjusting	adjust	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	55	23	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	24	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	25	fixed	fix	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	26	effects	effect	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	55	27	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	55	28	patient	patient	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	55	29	variables	variable	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	55	30	including	include	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	55	31	age	age	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	32	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	55	33	gender	gender	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	34	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	55	35	race	race	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	36	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	55	37	payer	payer	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	38	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	55	39	diagnosis	diagnosis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	40	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	55	41	related	relate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	42	grouping	grouping	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	43	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	55	44	concomitant	concomitant	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	55	45	conditions	condition	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	55	46	including	include	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	55	47	diabetes	diabetes	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	48	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	55	49	dialy-	dialy-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	55	50	sis	sis	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	55	51	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	55	52	lung	lung	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	53	disease	disease	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	55	54	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	56	1	RESULTS	RESULTS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	56	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	56	3	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	56	4	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	5	infection	infection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	6	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	56	7	reported	report	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	8	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	9	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	56	10	discharge	discharge	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	11	diagnosis	diagnosis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	12	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	13	1.0	1.0	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	56	14	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	15	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	16	all	all	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	56	17	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	18	inpatients	inpatient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	56	19	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	56	20	or	or	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	56	21	389,963	389,963	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	56	22	stays	stay	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	56	23	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	56	24	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	56	25	2003	2003	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	56	26	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	57	1	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	57	2	aureus	aureus	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	57	3	infection	infection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	4	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	5	stays	stay	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	57	6	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	57	7	significantly	significantly	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	57	8	more	more	RBR
work_kxfbgxp3ofbvng72zikzrcr6zm	57	9	likely	likely	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	57	10	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	11	male	male	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	57	12	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	57	13	older	old	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	57	14	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	57	15	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	57	16	stays	stay	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	57	17	that	that	WDT
work_kxfbgxp3ofbvng72zikzrcr6zm	57	18	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	57	19	paid	pay	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	20	by	by	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	21	Medicare	Medicare	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	57	22	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	57	23	white	white	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	57	24	or	or	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	57	25	non	non	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	57	26	-	-	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	57	27	Hispanics	Hispanics	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	57	28	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	57	29	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	30	stays	stay	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	57	31	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	32	individuals	individual	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	57	33	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	34	diabetes	diabetes	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	35	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	57	36	lung	lung	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	37	disease	disease	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	38	or	or	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	57	39	dialysis	dialysis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	57	40	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	58	1	After	after	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	2	adjusting	adjust	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	58	3	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	4	covariates	covariate	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	5	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	58	6	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	58	7	mean	mean	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	58	8	incremental	incremental	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	58	9	impact	impact	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	10	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	11	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	58	12	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	13	infection	infection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	14	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	15	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	16	charges	charge	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	17	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	58	18	length	length	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	19	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	58	20	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	21	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	58	22	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	23	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	24	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	25	37,251	37,251	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	26	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	27	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	28	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	29	Confidence	Confidence	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	58	30	Interval	Interval	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	58	31	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	32	CI	CI	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	58	33	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	34	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	58	35	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	36	34,678–$39,823	34,678–$39,823	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	37	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	38	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	58	39	8.2	8.2	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	40	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	41	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	42	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	43	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	44	CI	ci	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	45	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	58	46	7.9–8.5	7.9–8.5	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	47	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	48	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	49	all	all	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	58	50	inpatient	inpatient	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	51	stays	stay	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	52	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	58	53	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	54	40,637	40,637	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	55	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	56	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	57	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	58	CI	ci	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	59	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	58	60	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	61	37,683–$43,591	37,683–$43,591	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	62	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	63	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	58	64	9.2	9.2	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	65	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	66	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	67	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	68	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	69	CI	ci	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	70	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	58	71	8.8–9.6	8.8–9.6	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	72	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	73	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	74	surgical	surgical	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	58	75	stays	stay	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	76	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	58	77	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	78	83,952	83,952	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	79	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	80	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	81	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	82	CI	ci	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	83	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	58	84	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	85	75,853–$92,052	75,853–$92,052	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	86	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	87	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	58	88	16.8	16.8	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	89	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	90	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	91	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	92	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	93	CI:15.7–17.9	ci:15.7–17.9	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	94	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	95	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	96	invasive	invasive	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	58	97	cardiovascular	cardiovascular	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	58	98	stays	stay	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	99	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	58	100	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	101	34,202	34,202	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	102	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	103	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	104	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	105	CI	ci	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	106	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	58	107	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	108	29,612–$38,791	29,612–$38,791	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	109	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	110	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	58	111	9.6	9.6	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	112	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	113	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	114	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	115	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	116	CI	ci	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	117	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	58	118	9.0–10.2	9.0–10.2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	58	119	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	120	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	121	invasive	invasive	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	58	122	orthopedic	orthopedic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	58	123	stays	stay	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	124	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	58	125	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	126	119,292	119,292	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	127	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	128	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	129	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	130	CI	ci	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	131	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	58	132	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	58	133	106,209–$132,374	106,209–$132,374	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	134	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	135	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	58	136	19.8	19.8	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	137	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	138	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	139	95	95	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	140	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	141	CI	ci	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	142	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	58	143	17.5–22.2	17.5–22.2	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	58	144	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	58	145	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	58	146	invasive	invasive	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	58	147	neurosurgical	neurosurgical	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	58	148	stays	stay	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	58	149	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	59	1	CONCLUSION	CONCLUSION	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	59	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	59	3	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	59	4	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	59	5	infections	infection	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	59	6	present	present	VBP
work_kxfbgxp3ofbvng72zikzrcr6zm	59	7	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	59	8	considerable	considerable	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	59	9	economic	economic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	59	10	burden	burden	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	59	11	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	59	12	U.S	U.S	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	59	13	hospitals	hospital	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	59	14	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	60	1	Based	base	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	2	on	on	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	3	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	60	4	prevalence	prevalence	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	5	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	6	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	60	7	aureus	aureus	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	60	8	infection	infection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	9	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	60	10	its	-PRON-	PRP$
work_kxfbgxp3ofbvng72zikzrcr6zm	60	11	incremental	incremental	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	60	12	impact	impact	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	13	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	60	14	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	60	15	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	60	16	economic	economic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	60	17	impact	impact	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	18	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	19	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	60	20	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	21	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	22	all	all	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	60	23	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	24	admissions	admission	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	60	25	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	60	26	estimated	estimate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	27	at	at	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	28	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	60	29	14.5	14.5	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	60	30	billion	billion	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	60	31	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	60	32	2004	2004	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	60	33	U.S.	U.S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	60	34	dollars	dollar	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	60	35	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	61	1	PIN23	PIN23	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	2	DETERMINANTS	determinant	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	61	3	OF	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	4	TOTAL	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	61	5	HOSPITAL	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	6	COSTS	costs	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	7	AMONG	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	8	INPATIENTS	inpatient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	61	9	WITH	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	10	CANDIDEMIA	CANDIDEMIA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	11	Lee	Lee	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	12	SP1	SP1	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	13	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	14	Bunz	Bunz	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	15	T2	t2	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	16	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	17	Gagne	Gagne	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	18	JJ2	JJ2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	19	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	20	Maio	Maio	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	21	V2	V2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	22	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	23	Goldfarb	Goldfarb	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	24	NI2	NI2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	25	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	26	Horn	Horn	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	27	DL2	DL2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	28	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	29	Swanson	Swanson	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	30	R3	R3	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	31	1Thomas	1Thomas	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	32	Jefferson	Jefferson	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	33	Univeristy	Univeristy	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	34	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	35	Philadelphia	Philadelphia	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	36	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	37	PA	PA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	38	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	39	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	40	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	41	2Thomas	2Thomas	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	42	Jefferson	Jefferson	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	43	University	University	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	44	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	45	Philadelphia	Philadelphia	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	46	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	47	PA	PA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	48	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	49	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	50	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	51	3Pfizer	3Pfizer	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	52	Inc	Inc	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	53	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	54	New	New	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	55	York	York	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	56	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	57	NY	NY	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	58	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	59	USA	USA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	60	OBJECTIVES	OBJECTIVES	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	61	61	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	61	62	To	to	TO
work_kxfbgxp3ofbvng72zikzrcr6zm	61	63	identify	identify	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	61	64	factors	factor	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	61	65	associated	associate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	66	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	67	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	61	68	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	69	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	61	70	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	71	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	61	72	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	73	candidemia	candidemia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	74	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	75	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	61	76	large	large	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	61	77	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	78	urban	urban	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	61	79	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	80	tertiary	tertiary	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	61	81	care	care	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	82	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	61	83	teaching	teaching	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	84	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	61	85	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	62	1	METHODS	methods	LS
work_kxfbgxp3ofbvng72zikzrcr6zm	62	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	62	3	This	this	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	62	4	retrospective	retrospective	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	62	5	cohort	cohort	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	62	6	study	study	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	62	7	examined	examine	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	62	8	hospitalizations	hospitalization	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	62	9	during	during	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	62	10	calendar	calendar	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	62	11	years	year	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	62	12	2004	2004	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	62	13	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	62	14	2005	2005	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	62	15	at	at	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	62	16	Thomas	Thomas	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	62	17	Jefferson	Jefferson	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	62	18	University	University	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	62	19	Hospital	Hospital	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	62	20	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	62	21	Philadelphia	Philadelphia	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	62	22	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	62	23	PA	PA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	62	24	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	62	25	using	use	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	62	26	data	datum	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	62	27	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	62	28	various	various	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	62	29	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	62	30	systems	system	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	62	31	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	63	1	Candidemia	candidemia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	2	cases	case	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	63	3	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	63	4	identified	identify	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	5	via	via	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	6	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	63	7	microbiological	microbiological	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	63	8	laboratory	laboratory	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	9	information	information	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	10	system	system	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	11	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	12	those	those	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	63	13	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	63	14	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	15	at	at	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	63	16	least	least	RBS
work_kxfbgxp3ofbvng72zikzrcr6zm	63	17	one	one	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	63	18	confirmed	confirm	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	63	19	positive	positive	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	63	20	blood	blood	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	21	culture	culture	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	22	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	23	any	any	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	63	24	Candida	Candida	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	63	25	species	specie	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	63	26	at	at	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	27	any	any	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	63	28	point	point	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	29	during	during	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	30	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	63	31	study	study	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	32	period	period	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	63	33	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	64	1	Demographic	demographic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	64	2	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	64	3	economic	economic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	64	4	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	64	5	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	64	6	clinical	clinical	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	64	7	data	datum	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	64	8	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	64	9	includ-	includ-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	64	10	ing	ing	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	64	11	length	length	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	64	12	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	64	13	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	64	14	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	64	15	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	64	16	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	64	17	LOS	LOS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	64	18	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	64	19	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	64	20	payer	payer	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	64	21	types	type	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	64	22	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	64	23	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	64	24	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	64	25	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	64	26	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	64	27	Diagnosis	Diagnosis	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	64	28	Related	Related	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	64	29	Group	Group	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	64	30	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	64	31	DRG	DRG	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	64	32	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	64	33	assignments	assignment	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	64	34	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	64	35	collected	collect	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	64	36	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	64	37	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	64	38	hos-	hos-	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	64	39	pital	pital	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	64	40	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	64	41	accounting	accounting	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	64	42	system	system	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	64	43	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	65	1	Pharmacy	pharmacy	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	65	2	data	datum	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	65	3	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	65	4	i.e.	i.e.	FW
work_kxfbgxp3ofbvng72zikzrcr6zm	66	1	medications	medication	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	66	2	administered	administer	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	66	3	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	66	4	associated	associate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	66	5	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	66	6	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	66	7	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	66	8	retrieved	retrieve	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	66	9	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	66	10	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	66	11	phar-	phar-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	66	12	macy	macy	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	66	13	electronic	electronic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	66	14	information	information	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	66	15	system	system	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	66	16	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	67	1	A	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	67	2	multivariate	multivariate	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	67	3	regression	regression	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	67	4	analysis	analysis	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	67	5	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	67	6	using	use	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	67	7	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	67	8	natural	natural	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	67	9	logarithm	logarithm	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	67	10	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	67	11	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	67	12	hospitalization	hospitalization	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	67	13	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	67	14	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	67	15	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	67	16	dependent	dependent	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	67	17	variable	variable	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	67	18	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	67	19	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	67	20	conducted	conduct	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	67	21	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	68	1	Independent	independent	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	68	2	variables	variable	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	68	3	included	include	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	68	4	demographic	demographic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	68	5	information	information	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	68	6	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	68	7	relative	relative	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	68	8	DRG	DRG	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	68	9	weights	weight	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	68	10	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	68	11	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	68	12	Candida	Candida	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	68	13	species	specie	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	68	14	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	69	1	RESULTS	RESULTS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	69	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	69	3	Among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	69	4	68,526	68,526	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	69	5	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	69	6	hospitalizations	hospitalization	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	69	7	during	during	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	69	8	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	69	9	study	study	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	69	10	period	period	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	69	11	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	69	12	287	287	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	69	13	cases	case	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	69	14	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	69	15	con-	con-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	69	16	firmed	firm	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	69	17	positive	positive	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	69	18	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	69	19	candidemia	candidemia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	69	20	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	70	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	70	2	mean	mean	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	70	3	age	age	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	70	4	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	70	5	cases	case	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	70	6	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	70	7	58	58	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	70	8	years	year	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	70	9	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	70	10	52	52	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	70	11	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	70	12	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	70	13	female	female	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	70	14	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	70	15	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	70	16	60	60	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	70	17	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	70	18	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	70	19	Caucasian	caucasian	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	70	20	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	71	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	71	2	mean	mean	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	71	3	LOS	LOS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	71	4	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	71	5	43.3	43.3	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	71	6	days	day	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	71	7	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	71	8	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	71	9	average	average	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	71	10	inpatient	inpatient	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	71	11	cost	cost	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	71	12	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	71	13	candidemia	candidemia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	71	14	cases	case	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	71	15	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	71	16	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	71	17	130,759	130,759	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	71	18	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	71	19	SD	SD	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	71	20	=	=	SYM
work_kxfbgxp3ofbvng72zikzrcr6zm	71	21	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	71	22	116,560	116,560	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	71	23	;	;	:
work_kxfbgxp3ofbvng72zikzrcr6zm	71	24	median	median	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	71	25	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	71	26	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	71	27	97,869	97,869	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	71	28	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	71	29	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	72	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	72	2	most	most	RBS
work_kxfbgxp3ofbvng72zikzrcr6zm	72	3	common	common	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	72	4	Candida	Candida	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	72	5	species	specie	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	72	6	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	72	7	C.	C.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	72	8	albicans	albicans	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	72	9	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	72	10	n	n	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	72	11	=	=	SYM
work_kxfbgxp3ofbvng72zikzrcr6zm	72	12	127	127	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	72	13	;	;	:
work_kxfbgxp3ofbvng72zikzrcr6zm	72	14	44	44	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	72	15	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	72	16	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	72	17	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	73	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	73	2	most	most	RBS
work_kxfbgxp3ofbvng72zikzrcr6zm	73	3	commonly	commonly	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	73	4	used	use	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	73	5	antifungal	antifungal	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	73	6	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	73	7	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	73	8	fluconazole	fluconazole	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	73	9	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	73	10	N	n	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	73	11	=	=	SYM
work_kxfbgxp3ofbvng72zikzrcr6zm	73	12	176	176	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	73	13	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	73	14	61	61	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	73	15	%	%	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	73	16	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	73	17	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	74	1	Age	age	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	74	2	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	74	3	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	74	4	relative	relative	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	74	5	DRG	drg	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	74	6	weights	weight	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	74	7	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	74	8	p	p	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	74	9	<	<	XX
work_kxfbgxp3ofbvng72zikzrcr6zm	74	10	0.05	0.05	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	74	11	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	74	12	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	74	13	significantly	significantly	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	74	14	positively	positively	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	74	15	correlated	correlate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	74	16	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	74	17	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	74	18	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	74	19	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	74	20	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	75	1	Older	old	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	75	2	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	75	3	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	75	4	higher	high	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	75	5	relative	relative	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	75	6	DRG	DRG	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	75	7	weights	weight	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	75	8	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	75	9	associated	associate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	75	10	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	75	11	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	75	12	higher	high	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	75	13	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	75	14	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	75	15	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	76	1	Race	race	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	76	2	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	76	3	gender	gender	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	76	4	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	76	5	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	76	6	marital	marital	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	76	7	status	status	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	76	8	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	76	9	not	not	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	76	10	associated	associate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	76	11	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	76	12	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	76	13	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	76	14	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	77	1	CONCLUSION	conclusion	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	77	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	77	3	Relative	relative	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	77	4	DRG	DRG	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	77	5	weights	weight	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	77	6	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	77	7	as	as	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	77	8	well	well	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	77	9	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	77	10	age	age	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	77	11	are	be	VBP
work_kxfbgxp3ofbvng72zikzrcr6zm	77	12	associated	associate	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	77	13	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	77	14	total	total	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	77	15	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	77	16	costs	cost	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	77	17	among	among	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	77	18	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	77	19	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	77	20	candidemia	candidemia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	77	21	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	78	1	Candidemia	candidemia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	78	2	is	be	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	78	3	expensive	expensive	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	78	4	to	to	TO
work_kxfbgxp3ofbvng72zikzrcr6zm	78	5	treat	treat	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	78	6	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	78	7	results	result	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	78	8	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	78	9	lengthy	lengthy	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	78	10	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	78	11	stay	stay	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	78	12	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	79	1	Early	early	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	79	2	detection	detection	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	79	3	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	79	4	treatment	treatment	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	79	5	may	may	MD
work_kxfbgxp3ofbvng72zikzrcr6zm	79	6	significantly	significantly	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	79	7	reduce	reduce	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	79	8	resource	resource	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	79	9	use	use	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	79	10	as	as	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	79	11	well	well	RB
work_kxfbgxp3ofbvng72zikzrcr6zm	79	12	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	79	13	improve	improve	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	79	14	outcomes	outcome	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	79	15	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	80	1	PIN24	PIN24	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	2	THE	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	80	3	ECONOMIC	economic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	80	4	IMPACT	impact	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	5	OF	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	6	METHICILLIN	METHICILLIN	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	7	RESISTANCE	RESISTANCE	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	8	IN	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	9	STAPHYLOCOCCUS	STAPHYLOCOCCUS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	10	AUREUS	AUREUS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	11	BACTEREMIA	BACTEREMIA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	12	IN	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	13	KOREA	KOREA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	14	Park	Park	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	15	EJ1	EJ1	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	16	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	17	Lee	Lee	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	18	EK2	EK2	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	19	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	20	Chae	Chae	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	21	S3	S3	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	22	1Korea	1Korea	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	23	Institute	Institute	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	24	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	25	Health	Health	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	26	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	80	27	Social	Social	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	28	Afffairs	Afffairs	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	80	29	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	30	Seoul	Seoul	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	31	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	32	South	South	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	33	Korea	Korea	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	34	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	35	2Sookmyung	2Sookmyung	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	36	Women	Women	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	37	’s	’s	POS
work_kxfbgxp3ofbvng72zikzrcr6zm	80	38	University	University	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	39	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	40	Seoul	Seoul	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	41	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	42	South	South	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	43	Korea	Korea	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	44	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	45	3Korea	3Korea	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	46	Institute	Institute	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	47	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	48	Health	Health	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	49	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	80	50	Social	Social	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	51	Affairs	Affairs	NNPS
work_kxfbgxp3ofbvng72zikzrcr6zm	80	52	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	53	Seoul	Seoul	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	54	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	55	South	South	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	56	Korea	Korea	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	57	OBJECTIVES	OBJECTIVES	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	58	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	80	59	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	80	60	objective	objective	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	61	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	62	this	this	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	80	63	study	study	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	64	is	be	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	80	65	to	to	TO
work_kxfbgxp3ofbvng72zikzrcr6zm	80	66	examine	examine	VB
work_kxfbgxp3ofbvng72zikzrcr6zm	80	67	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	80	68	eco-	eco-	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	80	69	nomic	nomic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	80	70	outcome	outcome	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	71	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	72	Methicillin	Methicillin	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	73	resistance	resistance	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	74	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	75	Staphylococcus	Staphylococcus	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	76	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	77	bacteremia	bacteremia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	78	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	79	Korea	Korea	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	80	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	80	81	where	where	WRB
work_kxfbgxp3ofbvng72zikzrcr6zm	80	82	MRSA	MRSA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	80	83	is	be	VBZ
work_kxfbgxp3ofbvng72zikzrcr6zm	80	84	endemic	endemic	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	80	85	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	86	major-	major-	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	80	87	ity	ity	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	88	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	80	89	hospitals	hospital	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	80	90	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	81	1	METHODS	methods	LS
work_kxfbgxp3ofbvng72zikzrcr6zm	81	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	81	3	We	-PRON-	PRP
work_kxfbgxp3ofbvng72zikzrcr6zm	81	4	conducted	conduct	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	81	5	retrospective	retrospective	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	81	6	case-	case-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	81	7	control	control	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	81	8	study	study	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	81	9	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	81	10	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	81	11	admitted	admit	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	81	12	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	81	13	three	three	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	81	14	university	university	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	81	15	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	81	16	based	base	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	81	17	teaching	teaching	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	81	18	hospitals	hospital	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	81	19	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	81	20	Seoul	Seoul	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	81	21	,	,	,
work_kxfbgxp3ofbvng72zikzrcr6zm	81	22	Korea	Korea	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	81	23	in	in	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	81	24	2005	2005	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	81	25	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	82	1	Cases	case	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	82	2	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	82	3	defined	define	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	4	as	as	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	5	patients	patient	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	82	6	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	7	Methicillin	Methicillin	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	82	8	-	-	HYPH
work_kxfbgxp3ofbvng72zikzrcr6zm	82	9	resistant	resistant	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	82	10	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	82	11	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	12	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	82	13	MRSA	MRSA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	82	14	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	82	15	bac-	bac-	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	82	16	teremia	teremia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	17	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	82	18	controls	control	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	82	19	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	82	20	Methicillin-	Methicillin-	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	82	21	susceptible	susceptible	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	82	22	S.	S.	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	82	23	aureus	aureus	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	24	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	82	25	MSSA	MSSA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	82	26	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	82	27	bacteremia	bacteremia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	28	selected	select	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	29	according	accord	VBG
work_kxfbgxp3ofbvng72zikzrcr6zm	82	30	to	to	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	31	a	a	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	82	32	priori	priori	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	82	33	matching	matching	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	34	cri-	cri-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	82	35	teria	teria	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	82	36	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	83	1	58	58	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	83	2	cases	case	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	83	3	and	and	CC
work_kxfbgxp3ofbvng72zikzrcr6zm	83	4	58	58	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	83	5	controls	control	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	83	6	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	83	7	identified	identify	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	83	8	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	84	1	Hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	84	2	charges	charge	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	84	3	were	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	84	4	collected	collect	VBN
work_kxfbgxp3ofbvng72zikzrcr6zm	84	5	from	from	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	84	6	hospitals	hospital	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	84	7	’	’	POS
work_kxfbgxp3ofbvng72zikzrcr6zm	84	8	billing	billing	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	84	9	system	system	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	84	10	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	85	1	RESULTS	RESULTS	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	85	2	:	:	:
work_kxfbgxp3ofbvng72zikzrcr6zm	85	3	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	85	4	median	median	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	85	5	hospital	hospital	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	6	charge	charge	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	7	after	after	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	8	the	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	85	9	development	development	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	10	of	of	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	11	bacteremia	bacteremia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	12	was	be	VBD
work_kxfbgxp3ofbvng72zikzrcr6zm	85	13	higher	high	JJR
work_kxfbgxp3ofbvng72zikzrcr6zm	85	14	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	15	cases	case	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	85	16	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	17	MRSA	MRSA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	85	18	bacteremia	bacteremia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	19	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	85	20	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	85	21	8245	8245	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	85	22	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	85	23	than	than	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	24	for	for	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	25	con-	con-	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	26	trols	trol	NNS
work_kxfbgxp3ofbvng72zikzrcr6zm	85	27	with	with	IN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	28	MSSA	MSSA	NNP
work_kxfbgxp3ofbvng72zikzrcr6zm	85	29	bacteremia	bacteremia	NN
work_kxfbgxp3ofbvng72zikzrcr6zm	85	30	(	(	-LRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	85	31	$	$	$
work_kxfbgxp3ofbvng72zikzrcr6zm	85	32	6569	6569	CD
work_kxfbgxp3ofbvng72zikzrcr6zm	85	33	)	)	-RRB-
work_kxfbgxp3ofbvng72zikzrcr6zm	85	34	.	.	.
work_kxfbgxp3ofbvng72zikzrcr6zm	86	1	The	the	DT
work_kxfbgxp3ofbvng72zikzrcr6zm	86	2	median	median	JJ
work_kxfbgxp3ofbvng72zikzrcr6zm	86	3	hospital	hospital	NN